Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ariela Noy, MD
Memorial Sloan Kettering Cancer Center
Study Chair - Henry Koon, MD
Beth Israel Deaconess Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Siteman Cancer Center at Barnes-Jewish Hospital
St Louis, Missouri, United States
- Memorial Sloan - Kettering Cancer Center
New York, New York, United States
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
The Bronx, New York, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Joan Karnell Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2005
- Primary completion
- 31 Dec 2009
- Completion
- 31 Dec 2009
- Last update posted
- 6 Jun 2018
- Registered enrollment
- 30
- Registry id
- NCT00090987
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.